BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1666432)

  • 1. Morphine-6-glucuronide and morphine: mu-opioid receptor binding and effects on dopamine-sensitive adenylate cyclase in striatum.
    Christensen CB; Mørk A; Geisler A
    Pharmacol Toxicol; 1991 Nov; 69(5):396-8. PubMed ID: 1666432
    [No Abstract]   [Full Text] [Related]  

  • 2. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of opioid agonists selective for three subclasses of opioid receptors and one sigma receptor agonist on dopamine stimulated adenylate cyclase in rat caudate nucleus.
    Grynne BH; Holmen AT; Enger M; Maurset AR
    Pharmacol Toxicol; 1991 Nov; 69(5):338-40. PubMed ID: 1666431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-6-glucuronide: receptor binding profile in bovine caudate nucleus.
    Christensen CB; Reiff L
    Pharmacol Toxicol; 1991 Feb; 68(2):151-3. PubMed ID: 1649469
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of morphine of prostaglandin E2 (PGE2)-sensitive adenylate cyclase in corpus striatum of rats and its cellular localization by using kainic acid.
    Havemann U; Kuschinsky K
    Brain Res; 1978 Jul; 150(2):441-5. PubMed ID: 209852
    [No Abstract]   [Full Text] [Related]  

  • 7. Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide.
    Hucks D; Thompson PI; McLoughlin L; Joel SP; Patel N; Grossman A; Rees LH; Slevin ML
    Br J Cancer; 1992 Jan; 65(1):122-6. PubMed ID: 1310249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
    Van Vliet BJ; De Vries TJ; Wardeh G; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1991 Oct; 208(2):105-11. PubMed ID: 1666051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine.
    Clouet DH; Iwatsubo K
    Life Sci; 1975 Jul; 17(1):35-40. PubMed ID: 238090
    [No Abstract]   [Full Text] [Related]  

  • 11. Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons.
    van Vliet BJ; Mulder AH; Schoffelmeer AN
    Prog Clin Biol Res; 1990; 328():409-12. PubMed ID: 2154799
    [No Abstract]   [Full Text] [Related]  

  • 12. Mu and delta opiate receptors in neuronal and astroglial primary cultures from various regions of the brain--coupling with adenylate cyclase, localisation on the same neurones and association with dopamine (D1) receptor adenylate cyclase.
    Eriksson PS; Hansson E; Rönnbäck L
    Neuropharmacology; 1991 Nov; 30(11):1233-9. PubMed ID: 1663598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
    Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
    Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.
    Tang LC; Cotzias GC
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1546-8. PubMed ID: 206908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
    Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
    Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of chronic agonist administration on mu-opioid receptor- and muscarinic receptor-regulated adenylate cyclase in rat striatal neurons.
    Van Vliet BJ; Dotman CH; Wardeh G; Mulder AH; Schoffelmeer AN
    Life Sci; 1992; 51(10):PL89-94. PubMed ID: 1325016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptors inhibit the adenylate cyclase in guinea pig cochleas.
    Eybalin M; Pujol R; Bockaert J
    Brain Res; 1987 Sep; 421(1-2):336-42. PubMed ID: 2825909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic SCH 23390 produces tolerance to morphine extrapyramidal effects.
    De Montis MG; Devoto P; Saba P; Porcella A; Meloni D; Tagliamonte A
    Pharmacol Res Commun; 1988 Dec; 20(12):1115-6. PubMed ID: 2850585
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells.
    Puttfarcken PS; Cox BM
    Life Sci; 1989; 45(20):1937-42. PubMed ID: 2557508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.